SI
CORT icon

Scout Investments’s Corcept Therapeutics CORT Stock Holding History

Scout Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.79M Buy
+149,569
New +$5.31M 0.18% 151

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Scout Investments's CORT Position: Q3 2024 in Review

Scout Investments opened a new position in Corcept Therapeutics (CORT) in Q3 2024: 149,569 shares worth $6.79M. The stake represents 0.18% of the portfolio and ranks #151 among its holdings.

321 funds tracked by Wall St. Rank hold CORT as of Q3 2024.

  • Scout Investments held 149,569 shares of Corcept Therapeutics worth $6.79M as of Q3 2024.
  • Corcept Therapeutics was a new Scout Investments position in Q3 2024.
  • Corcept Therapeutics made up 0.18% of Scout Investments's portfolio in Q3 2024, its #151 holding.
  • 321 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2024.

Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.